Thomas M Diehl1, James R Barrett2, Daniel E Abbott3, Linda M Cherney Stafford4, Bret M Hanlon5, Qiuyu Yang6, Rachel Van Doorn7, Sharon M Weber8, Corrine I Voils9. 1. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA. Electronic address: tdiehl@uwhealth.org. 2. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA. Electronic address: jbarrett2@uwhealth.org. 3. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA. Electronic address: abbott@surgery.wisc.edu. 4. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA. Electronic address: cherneystafford@surgery.wisc.edu. 5. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA; Department of Biostatistics and Medical Informatics, University of Wisconsin, WARF Room 201, 610 Walnut Street, Madison, WI 53726, USA. Electronic address: bmhanlon@wisc.edu. 6. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA; Department of Biostatistics and Medical Informatics, University of Wisconsin, WARF Room 201, 610 Walnut Street, Madison, WI 53726, USA. Electronic address: qyang92@wisc.edu. 7. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA. Electronic address: rvandoorn@wisc.edu. 8. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA. Electronic address: webers@surgery.wisc.edu. 9. University of Wisconsin, School of Medicine and Public Health, 750 Highland Ave, Madison, WI 53726, USA; William S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace (151), Madison, WI 53705, USA. Electronic address: voils@surgery.wisc.edu.
Abstract
BACKGROUND: Hospital readmissions are estimated to cost $17.4 billion per year in the Medicare population alone, with readmission rates as high as 30% for patients undergoing complex abdominal surgery. Improved transitional care and self-monitoring may reduce preventable readmissions for such high-risk populations. In this study, we will conduct a single-institution randomized controlled trial (RCT) to assess the effect of a novel transitional care mobile app, MobiMD, on hospital readmission in complex abdominal surgery patients. METHODS: Three hundred patients will be randomized 1:1 to standard of care (SOC) versus SOC plus MobiMD app in a parallel, single-blinded, two-arm RCT. Eligible patients are those who undergo complex abdominal surgery in the division of Surgical Oncology, Colorectal Surgery or Transplant Surgery. The MobiMD app provides push notification reminders directly to the patient's smart device, prompting them to enter clinical data and patient-reported outcomes. Clinical data collected via the MobiMD app include vital signs, red flag symptoms, daily wound and surgical drain images, ostomy output, drain output, medication compliance, and wound care compliance. These data are reviewed daily by a physician. The primary outcome is the proportion of participants readmitted to the hospital within 30 days of surgery. Secondary outcomes are 90-day hospital readmission, emergency department and urgent care visits, complication severity, and total readmission cost. DISCUSSION: If effective, mobile health apps such as MobiMD could be routinely integrated into surgical transitional care programs to minimize unnecessary hospital readmissions, emergency department visits and healthcare resource utilization. Clinical trials identifier: NCT04540315. Published by Elsevier Inc.
BACKGROUND: Hospital readmissions are estimated to cost $17.4 billion per year in the Medicare population alone, with readmission rates as high as 30% for patients undergoing complex abdominal surgery. Improved transitional care and self-monitoring may reduce preventable readmissions for such high-risk populations. In this study, we will conduct a single-institution randomized controlled trial (RCT) to assess the effect of a novel transitional care mobile app, MobiMD, on hospital readmission in complex abdominal surgery patients. METHODS: Three hundred patients will be randomized 1:1 to standard of care (SOC) versus SOC plus MobiMD app in a parallel, single-blinded, two-arm RCT. Eligible patients are those who undergo complex abdominal surgery in the division of Surgical Oncology, Colorectal Surgery or Transplant Surgery. The MobiMD app provides push notification reminders directly to the patient's smart device, prompting them to enter clinical data and patient-reported outcomes. Clinical data collected via the MobiMD app include vital signs, red flag symptoms, daily wound and surgical drain images, ostomy output, drain output, medication compliance, and wound care compliance. These data are reviewed daily by a physician. The primary outcome is the proportion of participants readmitted to the hospital within 30 days of surgery. Secondary outcomes are 90-day hospital readmission, emergency department and urgent care visits, complication severity, and total readmission cost. DISCUSSION: If effective, mobile health apps such as MobiMD could be routinely integrated into surgical transitional care programs to minimize unnecessary hospital readmissions, emergency department visits and healthcare resource utilization. Clinical trials identifier: NCT04540315. Published by Elsevier Inc.
Entities:
Keywords:
Health services research; Mobile app; Mobile health; Readmissions; Telemedicine; Transitional care
Authors: Elizabeth C Wick; Andrew D Shore; Kenzo Hirose; Andrew M Ibrahim; Susan L Gearhart; Jonathan Efron; Jonathan P Weiner; Martin A Makary Journal: Dis Colon Rectum Date: 2011-12 Impact factor: 4.585
Authors: Diane W Chen; Rachel W Davis; Courtney J Balentine; Aaron R Scott; Yue Gao; Nicole M Tapia; David H Berger; James W Suliburk Journal: J Surg Res Date: 2014-04-21 Impact factor: 2.192